Morning Briefing: AngioDynamics’ Q1 2025 Earnings Review
On October 3, 2024, AngioDynamics, Inc. (NASDAQ:ANGO) hosted its fiscal year 2025 first quarter earnings conference call, featuring President and CEO Jim Clemmer and Executive VP and CFO Steve Trowbridge. The call was moderated by John Young from Canaccord Genuity and Yi Chen from H.C. Wainwright.
The company’s Q1 2025 earnings release was made public earlier that morning and is available on AngioDynamics’ website. The call was also broadcast live online and a replay will be available on the website approximately one hour after the call’s conclusion.
Before diving into the discussion, the operator reminded listeners that forward-looking statements would be made regarding AngioDynamics’ future performance, including revenue, adjusted earnings, and gross margin projections for fiscal year 2025. Investors were encouraged to review the company’s SEC filings, including its Form 10-Q and 10-K, to understand potential factors that may impact actual results.
Throughout the call, management discussed non-GAAP and pro forma financial measures, which are used to set operational goals, assess performance, and provide insight into the company’s underlying trends. These measures are intended to assist investors in analyzing AngioDynamics’ business over time.
Leave a Reply